scispace - formally typeset
Posted ContentDOI

Supplementary Tables S1-S6 from Quantified Tumor T1 Is a Generic Early-Response Imaging Biomarker for Chemotherapy Reflecting Cell Viability

TLDR
In this paper , a generic early-response imaging biomarker for Chemotherapy Reflecting Cell Viability was proposed. But this biomarker is not suitable for use in the treatment of cancer.
Abstract: 
Supplementary Tables S1-S6 from Quantified Tumor T1 Is a Generic Early-Response Imaging Biomarker for Chemotherapy Reflecting Cell Viability

read more

Content maybe subject to copyright    Report

Related Papers (5)

Volumetry based biomarker speed of growth: Quantifying the change of total tumor volume in whole-body magnetic resonance imaging over time improves risk stratification of smoldering multiple myeloma patients.

Markus Wennmann, +11 more
- 18 May 2018 - 

PENN biomarker core of the Alzheimer's disease Neuroimaging Initiative.

Leslie M. Shaw
- 01 Jan 2008 - 

Imaging Biomarker Applications in Oncology Drug Development

Janet C. Miller, +2 more
- 01 Sep 2007 - 

Biomarker evaluation for prognostic stratification of patients with COVID-19: the added value of quantitative chest CT

- 18 Feb 2022 - 

Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development

Ralph Sinkus, +4 more
- 01 Mar 2012 -